TP 53 Arg72Pro, GSTM1, GSTP1 Ile105Val and GSTT1 gene polymorphisms as predisposing factors for non-small cell lung cancer (NSCLC) developmentSource: Annual Congress 2006 - Molecular pathology and genetics of lung cancer Year: 2006
Influence of common p53 and XRCC1 variant alleles on risk of lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 810s Year: 2006
Analysis of XPD gene Lys751Gln polymorphism as predisposing factor for non-small cell lung cancer (NSCLC) development Source: Eur Respir J 2007; 30: Suppl. 51, 131s Year: 2007
Combined effect of p53 and XRCC1 gene polymorphisms on age-associated lung cancer risk Source: Annual Congress 2008 - Discovery of novel targets in lung disease by means of functional genomics Year: 2008
Arg72Pro and GSTM1 gene polymorphisms increase the risk of non small cell lung cancer (NSCLC) Source: Eur Respir J 2005; 26: Suppl. 49, 92s Year: 2005
Association of -93G®A polymorphism in the hMLH1 gene with susceptibility to and prognosis of non-small cell lung cancer in Taiwan Source: Eur Respir J 2006; 28: Suppl. 50, 151s Year: 2006
Occurrence and clinical significance of hOGG1 Ser326Cys polymorphism in NSCLC patients from northern Poland Source: Eur Respir J 2007; 30: Suppl. 51, 130s Year: 2007
Occurrence and clinical significance of hOGG1 Ser326Cys polymorphism in NSCLC patients from northern Poland Source: Eur Respir J 2006; 28: Suppl. 50, 812s Year: 2006
Association between H-RAS T81C genetic polymorphism with non-small cell Lung cancer Source: Virtual Congress 2020 – Biological mechanisms of lung cancer Year: 2020
Gene polymorphisms of p53 at codon 72 and MDM2 SNP309 are associated with lung cancer risk and emphysematous changes in smokers Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases Year: 2014
Genotyping single-nucleotide polymorphisms (SNP) in ERCC1, XPD, XRCC1, XRCC3 and MDR-1 and CCND-1 genes for response and toxicity prediction in chemotherapy of non small cell lung cancer (NSCLC) Source: Annual Congress 2007 - Biology in thoracic oncology Year: 2007
Association of XPD and CDA polymorphisms with clinical outcome in non-small cell lung cancer in a Chinese population Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012
A functional polymorphism in XRCC1 gene is associated with lung cancer risk in a Korean population Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014
Genetic polymorphisms and lung cancer susceptibility in a Brazilian population Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases Year: 2008
Association of GSTT1, GSTM1 and CYP1A1 MSP1 gene polymorphism with lung cancer patients in north Indian population Source: Annual Congress 2010 - Epidemiology of lung cancer Year: 2010
Genetic polymorphisms CYP1A1 m1 , GSTM1 , GSTT1 null and lung cancer susceptibility in a Brazilian population Source: Eur Respir J 2006; 28: Suppl. 50, 812s Year: 2006
Evaluation of EGFR mutations and ERCC2 polymorphisms in treatment of non-small cell lung cancer Source: Annual Congress 2005 - Chemotherapy and palliative care Year: 2005
P53 codon 72, GSST1, GSTM1 and CCR5del32 genetic polymorphism: Evidence of correlation between asthma and lung cancer Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015
Association of DNA repair gene XRCC7 G6721T polymorphisms withnon-small cell Lung cancer Source: International Congress 2019 – Epidemiology, genetics, air pollution and sleep Year: 2019
CYP1A1 polymorphisms and risk of lung cancer in a Brazilian populationSource: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases Year: 2008